AGH Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
AGH Wealth Advisors's VRTX Position: Q2 2026 in Review
AGH Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 0.86% in Q2 2026, buying an estimated $3.99K and bringing the position to 1,055 shares worth $524K. The position accounts for 0.33% of the portfolio, ranked #61.
AGH Wealth Advisors first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- AGH Wealth Advisors held 1,055 shares of Vertex Pharmaceuticals worth $524K as of Q2 2026.
- AGH Wealth Advisors bought 9 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.99K.
- Vertex Pharmaceuticals made up 0.33% of AGH Wealth Advisors's portfolio in Q2 2026, its #61 holding.
- AGH Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on AGH Wealth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.